Suzhou Zelgen Biopharmaceuticals Co. Ltd Financials

Market Capitalization CN¥25.67 Billion as of Jan. 1, 2026

Valuations Metrics as of Jan. 3, 2026

Trailing PE	-178.27
Forward PE	-1324.29
Price to Sales TTM	CN¥33.06
Price to Book MRQ	CN¥21.35
Enterprise to Revenue	31.76
Enterprise to EBITDA	-155.04

Financial Reports as of Jun. 30, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-06-30
Profit Margin	-17.96%
Operating Margin	-2.31%
Return on Assets TTM	-4.09%
Return on Equity TTM	-11.11%

Income Statement

Revenue TTM	CN¥742,277,312
Revenue per Share TTM	CN¥2.78
Quarterly Revenue Growth	51.90%
Gross Profit TTM	CN¥674,631,232
EBITDA	CN¥-152,076,720
Net Income to Common TTM	CN¥-133,343,968
Diluted EPS TTM	CN¥-0.50
Quarterly Earnings Growth YoY	57.04%

Balance Sheet

Total Cash MRQ	CN¥2,086,455,424
Total Cash per Share MRQ	CN¥7.88
Total Debt MRQ	CN¥
Total Debt to Equity MRQ	97.97
Current Ratio MRQ	1.85
Book Value per Share MRQ	CN¥4.34

Cash Flow

Operating Cash Flow TTM	CN¥-45,176,448
Levered Free Cash Flow TTM	CN¥-350,126,944

688266 Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding	264,708,186
Float Shares	163,248,185
Avg 10 Volume	1,925,918
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	29.79%
% Held by Institutions	31.34%

Stock Price Summary

Beta	0.20
Fifty Two Week Low	CN¥58.00
Fifty Two Week High	CN¥134.17
Fifty Two Week Change	34.59%
Day 50 MA	CN¥102.33
Day 200 MA	CN¥106.92

Dividends and Splits

Forward Annual Dividend Rate	CN¥
Forward Annual Dividend Yield	%
Trailing Annual Dividend Rate	CN¥0.00
Trailing Annual Dividend Yield	0.00%
Payout Ratio	0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date